Prescribing Information

Situation/Background: There is a supply problem with Humulin M3 Vials.  Resupply dates are now anticipated to be mid-June 2024. Initially a temporary switch to Humalog Mix 25 Vial was recommended as an alternative while Humulin M3 Vials were unavailable but now there is a supply problem with Humalog Mix 25 Vials. Resupply dates are currently anticipated to be

The latest medication shortage for diabetes now involves insulin – namely Humalog 10ml vials and Humulin M3. The former is usually prescribed for people on insulin pumps and the latter is most commonly used in older people with Type 2 diabetes (especially in care homes). As you will see from the attached guidance: For Humalog

There now do seem to be sufficient supplies of Rybelsus (oral semaglutide) to permit switching of patients on injectable agents, who have not been able to source an injection for more than 2 weeks. Please remember that there is a relative contraindication with Rybelsus for patients with diabetic retinopathy, although clearly for those with mild

Please do not double up on lower dose preparation where a higher dose of the GLP1-RA is not available. There have been reports of this happening and this will exacerbate the shortages. Patients should only be prescribed one dose from one pen – do not give multiple pen devices or multiple doses to make up a dose.

Dear colleagues, We are writing to provide an update on the national GLP1-RA supply situation for the indications of both type 2 diabetes and obesity. Please see the attached national patient safety alert (NPSA) for GLP1-RAs, issued on 3 January 2024 – here. This supersedes the previous publication from 2023. Main changes: We would encourage